Trending

This Pharma Stock is up 70% Pre-Market

(NASDAQ: VRNA) shares are soaring this morning on news, news, news. The company has an earnings call today, which will no doubt also include the discussions of a positive phase 3 study for COPD. The stock has surged to $11.90 this morning up 70% Volume is more than 4 million and there are more than 41,000 trades so far https://www.globenewswire.com/news-release/2022/08/09/2494468/0/en/Verona-Pharma-Announces-Ensifentrine-Meets-Primary-Endpoint-in-Phase-3-ENHANCE-2-Trial-for-COPD.html

RelatedNews

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist